Unpredictable DMD Progression Complicates Sarepta’s Gene Therapy Efficacy Claims

 
• By Derrick Gingery
  
choice
FDA reviewers must decide whether uncertainty outweighs DMD patients' need for the gene therapy as soon as possible. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies